-
Pill or Injection? Comparing Wegovy Options for Weight Loss
After huge anticipation, Wegovy’s oral tablet launched in the U.S. this January. By February, nearly 200,000 people were already using the pill. Health economists estimate it could add approximately $2.76 billion to overall Wegovy sales by 2030, with its share growing from about 3% in 2026 to 17% by 2031. At first glance, this momentum may suggest the pill is preferred over the once-weekly injection. However, that is not necessarily the case. Many individuals continue to prefer an injectable option, particularly when it better aligns with their routine or expectations. The choice between oral and injectable therapy is not straightforward.…
-
Three Takeaways From ADA Clinical Updates: Turning Standards Into Practice
If you work in diabetes care and education and are a member of the American Diabetes Association, you’ve likely received the nearly 400-page Standards of Care journal in your mailbox. What began as a three-page reference document in 1989 has grown into a comprehensive resource that now rivals a phonebook. The depth of guidance is incredibly valuable, but translating all of those standards into day-to-day clinical practice can feel a bit daunting. Enter the ADA Clinical Updates Conference, an important piece of the puzzle that focuses on moving evidence off the page and into real-world care. After spending the weekend…
-
Goodbye BMI? Why Body Composition Is Gaining Ground in Clinics
The rise of incretin-based therapies for obesity care, like Wegovy (semaglutide) and Zepbound (tirzepatide), has brought renewed attention to the risk of muscle atrophy that can accompany rapid weight loss. To better assess changes in skeletal muscle mass, clinicians are turning to body composition assessment tools to track progress over time. However, the ability to measure, interpret, and communicate changes in body composition is a skill most clinicians haven’t been formally trained in, leaving many feeling like it’s not a tool they can confidently use. I want to push back against that assumption and offer some basic principles to help…
